DIANNE MAWHIRTER: Open Payments
NPI 1942314414 · NORWALK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 29 payments from 17 companies in 2025. Trend: 2023 $327 · 2024 $342 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $100 |
| Astellas Pharma US Inc | 2 | $55 |
| Dexcom, Inc. | 2 | $46 |
| Corcept Therapeutics | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: Veozah, Dexcom G6 Transmitter, Korlym, Rybelsus, Cologuard Collection Kit, Wegovy, REXULTI, CAPLYTA.
Industry payments across OH — which companies pay providers there.
